Key Takeaways:
Scilex Holding Company (Nasdaq: SCLX) will issue a special dividend of common stock in its subsidiary Semnur Pharmaceuticals, Inc. (OTC: SMNR), with a record date of June 1, 2026.
"The dividend was approved by the company's board of directors," according to a statement released on May 22, 2026. The payment is intended to provide stockholders with direct equity in the late-stage pharmaceutical company.
Participating holders will receive one share of Semnur common stock for each share of Scilex common stock held. Scilex plans to distribute approximately 10.7 million of its roughly 186 million Semnur shares. The board noted that the payment date, to be set within 60 days of the record date, remains subject to change and the dividend could be revoked.
The move aims to unlock value for shareholders by giving them a direct stake in Semnur, a clinical late-stage company focused on developing non-opioid pain therapies, including its lead candidate SP-102 (SEMDEXA) for sciatica. Scilex itself focuses on commercializing non-opioid pain management products.
The announcement follows a mixed financial quarter for Scilex. The company reported first-quarter 2026 revenue of $8.6 million, a 72% increase year-over-year, driven by sales of its commercial products ZTlido and ELYXYB. However, its net loss attributable to common stockholders widened to $43.3 million from $26.1 million in the year-ago quarter, with a diluted loss per share of $(6.28).
Recent institutional holdings data shows a bearish sentiment, with 35 institutional investors decreasing their positions in the most recent quarter, compared with 15 who added shares. Additionally, company insiders have sold shares three times in the past six months, with no open market purchases, according to data from Quiver Quantitative.
The dividend provides a direct return to shareholders, but the conditional nature and recent insider sales warrant investor attention. The key date to watch is the payment date, which the board will determine within 60 days following the June 1 record date.
This article is for informational purposes only and does not constitute investment advice.
